C, G., OM, S., L, R., M, A., & N, B. (2025). Effective management of psoriasis and psoriatic arthritis in a patient with systemic lupus erythematosus using deucravacitinib, mycophenolate mofetil and hydroxychloroquine. Skin health and disease, 5(5), 403. https://doi.org/10.1093/skinhd/vzaf058
Chicago Style (17th ed.) CitationC, Gewiss, Steinmetz OM, Roth L, Augustin M, and Ben-Anaya N. "Effective Management of Psoriasis and Psoriatic Arthritis in a Patient with Systemic Lupus Erythematosus Using Deucravacitinib, Mycophenolate Mofetil and Hydroxychloroquine." Skin Health and Disease 5, no. 5 (2025): 403. https://doi.org/10.1093/skinhd/vzaf058.
MLA (9th ed.) CitationC, Gewiss, et al. "Effective Management of Psoriasis and Psoriatic Arthritis in a Patient with Systemic Lupus Erythematosus Using Deucravacitinib, Mycophenolate Mofetil and Hydroxychloroquine." Skin Health and Disease, vol. 5, no. 5, 2025, p. 403, https://doi.org/10.1093/skinhd/vzaf058.